GANX Annual CAPEX
$15.40 K
-$103.60 K-87.06%
31 December 2023
Summary:
As of January 23, 2025, GANX annual capital expenditures is $15.40 thousand, with the most recent change of -$103.60 thousand (-87.06%) on December 31, 2023. During the last 3 years, it has fallen by -$5400.00 (-25.96%). GANX annual CAPEX is now -87.06% below its all-time high of $119.00 thousand, reached on December 31, 2022.GANX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GANX Quarterly CAPEX
N/A
30 September 2024
Summary:
GANX quarterly capital expenditures is not available.GANX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GANX TTM CAPEX
N/A
30 September 2024
Summary:
GANX TTM capital expenditures is not available.GANX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GANX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.1% | - | - |
| 3 y3 years | -26.0% | - | - |
| 5 y5 years | +92.5% | - | - |
GANX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.1% | at low | ||||
| 5 y | 5-year | -87.1% | +12.4% | ||||
| alltime | all time | -87.1% | +92.5% |
Gain Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $15.40 K(-87.1%) | - | - |
| Mar 2023 | - | $11.00 K(+17.0%) | $122.20 K(+2.7%) |
| Dec 2022 | $119.00 K(+26.3%) | $9400.00(-83.6%) | $119.00 K(-1.4%) |
| Sept 2022 | - | $57.20 K(+28.3%) | $120.70 K(+26.3%) |
| June 2022 | - | $44.60 K(+471.8%) | $95.60 K(+30.1%) |
| Mar 2022 | - | $7800.00(-29.7%) | $73.50 K(-22.0%) |
| Dec 2021 | $94.20 K | - | - |
| Dec 2021 | - | $11.10 K(-65.4%) | $94.20 K(-3.6%) |
| Sept 2021 | - | $32.10 K(+42.7%) | $97.70 K(+45.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $22.50 K(-21.1%) | $67.00 K(+50.6%) |
| Mar 2021 | - | $28.50 K(+95.2%) | $44.50 K(+112.9%) |
| Dec 2020 | $20.80 K(+51.8%) | - | - |
| Dec 2020 | - | $14.60 K(+942.9%) | $20.90 K(+231.7%) |
| Sept 2020 | - | $1400.00(>+9900.0%) | $6300.00(+28.6%) |
| June 2020 | - | $0.00(-100.0%) | $4900.00(0.0%) |
| Mar 2020 | - | $4900.00 | $4900.00 |
| Dec 2019 | $13.70 K(+71.3%) | - | - |
| Dec 2018 | $8000.00 | - | - |
FAQ
- What is Gain Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Gain Therapeutics?
- What is Gain Therapeutics annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Gain Therapeutics?
- What is the all time high TTM CAPEX for Gain Therapeutics?
What is Gain Therapeutics annual capital expenditures?
The current annual CAPEX of GANX is $15.40 K
What is the all time high annual CAPEX for Gain Therapeutics?
Gain Therapeutics all-time high annual capital expenditures is $119.00 K
What is Gain Therapeutics annual CAPEX year-on-year change?
Over the past year, GANX annual capital expenditures has changed by -$103.60 K (-87.06%)
What is the all time high quarterly CAPEX for Gain Therapeutics?
Gain Therapeutics all-time high quarterly capital expenditures is $57.20 K
What is the all time high TTM CAPEX for Gain Therapeutics?
Gain Therapeutics all-time high TTM capital expenditures is $122.20 K